Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on November 5, 2026

Nov. 5, 2026

Vima Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial for Parkinson’s Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Indeterminate GlobeNewswire

Nov. 5, 2026

Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

Pyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO)

Indeterminate GlobeNewswire

Nov. 5, 2026

Iovance Biotherapeutics Reports Record Third Quarter 2026 Revenue of ~$122M, Business Achievements, and Corporate Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

Akebia Therapeutics Reports Positive Topline Data from VOCAL Trial Showing Vadadustat Dosed TIW Met Primary Endpoint of Non-Inferiority to ESA in Maintaining Hemoglobin

Indeterminate GlobeNewswire

Nov. 5, 2026

Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise

Indeterminate GlobeNewswire

Nov. 5, 2026

Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update 

Indeterminate GlobeNewswire

Nov. 5, 2026

Commerce Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Certara Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Apyx Medical Corporation Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Agility Becomes First U.S. Publicly Listed Pure-Play Humanoid Robotics Company, Begins Trading Today on Nasdaq as AGLT

Indeterminate GlobeNewswire

Nov. 5, 2026

Fate Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

Xunlei Limited Schedules 2026 Unaudited Third Quarter Earnings Release on November 12, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

OKYO Pharma to Present at the Stifel 2026 Healthcare Conference

Indeterminate GlobeNewswire

Nov. 5, 2026

Seer Secures Key Victory in ITC Patent Dispute as Investigative Staff Backs All Requested Remedies Against Nanomics

Indeterminate GlobeNewswire

Nov. 5, 2026

EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

GPGI Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 5, 2026

CareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA

Indeterminate GlobeNewswire

Nov. 5, 2026

Euro Stablecoins Added $263 Million in a Year, Up 54%, While Dollar Supply Fell

Indeterminate GlobeNewswire